BG

BioCity Group

Europe, Nottingham, United Kingdom, Nottingham

Description

BioCity Group is a business incubator that aides in the creation and development of life science businesses.

Investor Profile

BioCity Group has made 9 investments, with 0 in the past 12 months and 11% as lead.

Stage Focus

  • Series Unknown (56%)
  • Seed (22%)
  • Series A (11%)
  • Pre Seed (11%)

Country Focus

  • United Kingdom (78%)
  • United States (22%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Medical
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Life Science
  • Quality Assurance
  • Artificial Intelligence (Ai)
  • Data Integration
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BioCity Group frequently co-invest with?

Alderley Park Ventures
Europe, Nottingham, United Kingdom, Nottingham
Co-Investments: 3
UCB Ventures
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 2
Longwall Venture
Europe, Oxfordshire, United Kingdom, Harwell
Co-Investments: 1
Puffin Point
Europe, England, United Kingdom, London
Co-Investments: 1
TF
Europe, England, United Kingdom, London
Co-Investments: 2
Business Growth Fund
Europe, England, United Kingdom, London
Co-Investments: 1
Archangels
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1
Catapult Ventures
Europe, Leicester, United Kingdom, Enderby
Co-Investments: 1
Praetura Ventures
Europe, Manchester, United Kingdom, Manchester
Co-Investments: 1

Which angels does BioCity Group often collaborate with?

JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by BioCity Group?

NanoSyrinx

Coventry, Coventry, United Kingdom

NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick’s Medical School.

BiotechnologyMedicalTherapeutics
SeedJul 19, 2021
Amount Raised: $8,473,997
Rinri Therapeutics

Sheffield, Massachusetts, United States

Rinri Therapeutics is a biotechnology company developing a novel cell-based therapy.

BiotechnologyMedical
Series UnknownApr 20, 2021
Amount Raised: $12,032,507
Maxwellia

Alderley, Cheshire, United Kingdom

Maxwellia is a pioneering ‘prescription to over the counter’ medicines company.

BiopharmaHealth CarePharmaceutical
Series UnknownApr 8, 2021
Amount Raised: $4,394,753
Bio-Images Drug Delivery

Glasgow, Glasgow City, United Kingdom

Class leading experts in formulation work and scintigraphic clinical trials.

BiopharmaBiotechnologyHealth CareLife SciencePharmaceutical
Series UnknownDec 15, 2020
Amount Raised: $1,613,684
Kinomica

Alderley Park, Cheshire, United Kingdom

Kinomica is a proteomic-data science and diagnostics company specialising in cell signalling.

BiopharmaBiotechnology
Series ADec 14, 2020
Amount Raised: $5,197,062
NuVision

Nottingham, Nottingham, United Kingdom

NuVision™ is a biotechnology research and development spin out company from the University of Nottingham

BiotechnologyQuality AssuranceTherapeutics
Series UnknownSep 12, 2019
Amount Raised: $1,726,034
Kinomica

Alderley Park, Cheshire, United Kingdom

Kinomica is a proteomic-data science and diagnostics company specialising in cell signalling.

BiopharmaBiotechnology
Series UnknownAug 29, 2019
Rinri Therapeutics

Sheffield, Massachusetts, United States

Rinri Therapeutics is a biotechnology company developing a novel cell-based therapy.

BiotechnologyMedical
SeedMay 20, 2019
Amount Raised: $1,781,900
GENXT

Hinxton, Cambridgeshire, United Kingdom

GENXT.AI develops B2B solutions that streamline enterprise AI adoption, eliminating the risks of private data and ML model disclosure.

Artificial Intelligence (AI)Data IntegrationEnterprise SoftwareInformation TechnologyPaaSPrivacySecurity
Pre SeedJan 24, 2019
Amount Raised: $65,600